Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan · Delayed Price · Currency is TWD

47.40

-0.10 (-0.21%)

At close: Jul 9, 2026

-12.71% (1Y)

Market Cap	4.11B -4.1%
Revenue (ttm)	4.59B +3.3%
Net Income	-438.65M
EPS	-5.06
Shares Out	86.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	4.00 (8.42%)
Ex-Dividend Date	Jul 20, 2026

Volume	11,345
Open	46.60
Previous Close	47.50
Day's Range	46.25 - 47.50
52-Week Range	42.60 - 57.50
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include weight management, andrology, cardiovascular, respiratory, neurology, cardiovascular, metabolism, obstetrics and gynecology, antibiotic, immunology, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplements for liquid nutrition, regular blood lipids, L-arginines, agile movements, and improved sleep qualities under the N... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1982

Employees 339

Stock Exchange Taipei Exchange

Ticker Symbol 4120

Full Company Profile

Financial Performance

In 2025, Orient EuroPharma's revenue was 4.60 billion, an increase of 4.64% compared to the previous year's 4.39 billion. Losses were -567.39 million, 99.8% more than in 2024.

Financial Statements